Its Chai-2 platform has achieved a 16% success rate in creating functional antibodies from scratch—over 100 times better than ...
The Chinese firm has plenty of ambitions in the AI sector. Find out its latest developments, plans, and potential for success ...
This unprecedented infrastructure spending spree signals massive opportunity or dangerous overreach in an overheated AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback